Feedback?

Based on public information; not affiliated with or endorsed by the organisations named on this page.

PAT and process modelling (incl. AI/ML-assisted process development)

Suggested starting points, not a ranking

Process analytical technology, in-line monitoring, mechanistic and data-driven models, and AI/ML for process development. Each item is listed because its official text (or the call text on this site) mentions this theme: the matching sentence and its source are shown. Grouped by how open the route is, alphabetical within each group. This is not a ranking of companies or organisations.

7 items · Add this theme to My feed

1consortium or centre
1playbook
2related open calls

Related open calls on this theme

2 calls on this page, the same set as the list below. Only listed calls whose official text is tagged with this theme (from sourced evidence) are counted. These are open funding calls on this site, not grants offered by the companies or consortia on this page. Month chips are dated deadlines in the next 6 months only; rolling calls are not in the strip. Status segments jump to the matching section on this page.

0 open with a deadline2 rolling / any time0 opening soon

Deadlines in the next 6 months

  1. Nov 20260
  2. Dec 20260
  3. Jan 20270
  4. Feb 20270
  5. Mar 20270
  6. Apr 20270
View as a table
GroupItemCalls
Statusopen with a deadline0
Statusrolling / any time2
Statusopening soon0

Open to apply (5)

Calls and programmes researchers can apply to.

  • CompanyAstraZeneca (routes: Partnering enquiry (not a funding call) · Open to apply · Via a consortium or center; a programme may not cover this theme, see the company page)Matched text: It describes using machine learning to predict and optimise chemical reactions, to reduce waste, energy use and unwanted byproducts (archived page). source (www.astrazeneca.com)
  • CallEnabling Technologies Consortium (ETC) RFI/RFPs and third-party project proposals (Enabling Technologies Consortium (pharmaceutical member companies) · rolling / any time · industry-funded)Matched text: Recent requests covered crystal solubility prediction and solid–liquid separation. source (etconsortium.org)
  • CompanyMerck & Co., Inc. (routes: Open to apply · Via a consortium or center; a programme may not cover this theme, see the company page)Matched text: Optimization (APO) for Pharmaceutical Development", which it describes as applying data science and modeling, including Bayesian Optimization, to pharmaceutical process design. source (www.merck.com)
  • CompanyPfizer Inc. (routes: Open to apply · Partnering enquiry (not a funding call) · Via a consortium or center; a programme may not cover this theme, see the company page)Matched text: Pfizer lists advanced process analytical technologies (PAT), sensor integration and microfluidic sample handling compatible with continuous manufacturing, inline source (www.pfizer.com)
  • CallRinn Pharma & Biopharma (ex-SSPC) PhD positions (Rinn Pharma & Biopharma / SSPC · rolling / any time)Matched text: Drug Particle Engineering, Dosage Form Design, Predictive Materials Design & Model-Driven Process Control. source (rinn-biopharma.ie)

Ideas welcome (1)

The official page invites outside ideas or partnering enquiries, without a fixed call.

Playbooks (1)

Practical guides on this site that mention this theme in their official facts.

Other themes: Continuous crystallization · Polymorph and solid form control · Impurity rejection and purification · Particle engineering · Flow chemistry · Biocatalysis · Green and sustainable process · Microgravity crystallization · Continuous manufacturing